Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69?CD56dim cells - 19/04/17
Abstract |
Background |
In contrast to the extensive knowledge about human natural killer (NK) cells in peripheral blood, relatively little is known about NK cells in the human lung. Knowledge about the composition, differentiation, and function of human lung NK cells is critical to better understand their role in diseases affecting the lung, including asthma, chronic obstructive pulmonary disease, infections, and cancer.
Objective |
We sought to analyze and compare the phenotypic and functional characteristics of NK cells in the human lung and peripheral blood at the single-cell level.
Methods |
NK cells in human lung tissue and matched peripheral blood from 132 subjects were analyzed by using 16-color flow cytometry and confocal microscopy.
Results |
CD56dimCD16+ NK cells made up the vast majority of NK cells in human lungs, had a more differentiated phenotype, and more frequently expressed educating killer cell immunoglobulin-like receptors compared with NK cells in peripheral blood. Despite this, human lung NK cells were hyporesponsive toward target cell stimulation, even after priming with IFN-α. Furthermore, we detected a small subset of NK cells expressing CD69, a marker of tissue residency. These CD69+ NK cells in the lung consisted predominantly of immature CD56brightCD16− NK cells and less differentiated CD56dimCD16+ NK cells.
Conclusion |
Here, we characterize the major NK cell populations in the human lung. Our data suggest a model in which the majority of NK cells in the human lung dynamically move between blood and the lung rather than residing in the lung as bona fide tissue-resident CD69+ NK cells.
El texto completo de este artículo está disponible en PDF.Graphical abstract |
Key words : Natural killer cells, innate lymphoid cells, lung, differentiation, killer cell immunoglobulin-like receptor, CD69, tissue residency
Abbreviations used : ADCC, COPD, Eomes, FITC, ILC, KIR, NK, NKG, PE
Esquema
Supported by the Swedish Medical Research Council, the Strategic Research Foundation, the Swedish Cancer Society, the German Research Foundation (Grant MA-5449/1-1), the Swedish Heart-Lung Foundation, the Stockholm County Research Funds (ALF), the Karolinska Institutet Foundations, and the AZ Translational Medicine unconditional grant for the ChAMP project. |
|
Disclosure of potential conflict of interest: N. Marquardt has received a grant from the German Research Foundation (DFG). E. Kekäläinen has received grants from the Finnish Medical Foundation, Foundation for Pediatric Research Finland, Emil Aaltonen Foundation, Orion Research Foundation, Maud Kuistila Memory Foundation, Sigrid Jusélius Fellowship, Foundation of the Finnish Anti-Tuberculosis Association, and Jalmari and Rauha Ahokas Foundation. J. Mjösberg has received a grant from the Swedish Foundation for Medical Research (SSMF) and has consultant arrangements with ONO Pharmaceutical. M. L. Manson is employed by AstraZeneca. B. Dahlén has received grants from the Swedish Heart Lung Foundation, Swedish MRC, Stockholm County Council, Swedish Asthma and Allergy Association's Research Foundation, and Centre for Allergy Research, Karolinska Institutet; has consultant arrangements with Teva; and has received payment for lectures from the Swedish Food and Drug Regulatory Agency. S.-E. Dahlén has received grants from the Swedish MRC, Heart-Lung Foundation, Strategic Research Foundation, and ChAMP and has board memberships and consultant arrangements with AstraZeneca, GlaxoSmithKline, and RSPR AB. H.-G. Ljunggren has received grants from the Swedish Research Council, Swedish Cancer Society, and Swedish Foundation for Strategic Research. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 139 - N° 4
P. 1321 - avril 2017 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?